MYC as a regulator of ribosome biogenesis and protein synthesis
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
MYC regulates the transcription of thousands of genes required to coordinate a range of cellular processes, including those essential for proliferation, growth, differentiation, apoptosis and self-renewal. Recently, MYC has also been shown to serve as a direct regulator of ribosome biogenesis. MYC coordinates protein synthesis through the transcriptional control of RNA and protein components of ribosomes, and of gene products required for the processing of ribosomal RNA, the nuclear export of ribosomal subunits and the initiation of mRNA translation. We discuss how the modulation of ribosome biogenesis by MYC may be essential to its physiological functions as well as its pathological role in tumorigenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mechanical loading is also conveyed to the nucleolus through the transcription factor c-Myc”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“without sufficient induction of c-Myc, the expansion of translational capacity may be limited despite favorable metabolic conditions”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
In the citing paper
“Because this 45S transcript is rapidly processed and possesses a half-life measured in minutes, its abundance serves as an ultrasensitive, real-time indicator of active Pol I initiation and nucleolar stress [30,58].”
From Ribosome Biogenesis as a Putative Bottleneck to Skeletal Muscle Hypertrophy: Mechanisms, Human Evidence, and Practical Modulators (2026) · cites this paper as [58]
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism
Dang, C. V. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.1.1 · Cited by 1,715
Max: A Helix-Loop-Helix Zipper Protein That Forms a Sequence-Specific DNA-Binding Complex with Myc
Blackwood, E. M., & Eisenman, R. N. (1991) · Science · doi:10.1126/science.2006410 · Cited by 1,697
The Myc/Max/Mad Network and the Transcriptional Control of Cell Behavior
Grandori, C., Cowley, S. M., James, L. P., & Eisenman, R. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.653 · Cited by 1,333
Dang, C. V., O’Donnell, K. A., Zeller, K. I., Nguyen, T., Osthus, R. C., & Li, F. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2006.07.014 · Cited by 1,188 · cited 1×
“The deregulated expression of Myc proteins has been implicated in the development of a wide range of cancers (reviewed in Ref”
BackgroundTranscriptional regulation and transformation by Myc proteins
Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,131
Molecular mechanisms of translational control
Gebauer, F., & Hentze, M. W. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1488 · Cited by 991 · cited 1×
“The translational machinery is composed of ribosome subunits, mRNA, transfer RNAs (tRNAs), and translation initiation and elongation factors (reviewed in Ref”
BackgroundGenomic targets of the human c-Myc protein
Fernandez, P. C., Frank, S. R., Wang, L., Schroeder, M., Liu, S., Greene, J., Cocito, A., & Amati, B. (2003) · Genes & Development · doi:10.1101/gad.1067003 · Cited by 973
Does the ribosome translate cancer?
Ruggero, D., & Pandolfi, P. P. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1015 · Cited by 928
Cited by
Items 101–200 of 967
Long-range enhancers regulating Myc expression are required for normal facial morphogenesis
Uslu, V. V., Petretich, M., Ruf, S., Langenfeld, K., Fonseca, N. A., Marioni, J. C., & Spitz, F. (2014) · Nature Genetics · doi:10.1038/ng.2971 · Cited by 151
Koh, C. M., Gürel, B., Sutcliffe, S., Aryee, M. J., Schultz, D., Iwata, T., Uemura, M., Zeller, K. I., Anele, U. A., Zheng, Q., et al. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.12.040 · Cited by 144
Effect of low doses of actinomycin D on neuroblastoma cell lines
Cortés, C., Veiga, S. R., Almacellas, E., Hernández‐Losa, J., Ferreres, J. C., Kozma, S. C., Ambrosio, S., Thomas, G., & Tauler, A. (2016) · Molecular Cancer · doi:10.1186/s12943-015-0489-8 · Cited by 142
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
Dingar, D., Kalkat, M., Chan, P.-K., Srikumar, T., Bailey, S. D., Tu, W. B., Coyaud, E., Ponzielli, R., Kolyar, M., Jurisica, I., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2014.09.029 · Cited by 131
RP–MDM2–p53 Pathway: Linking Ribosomal Biogenesis and Tumor Surveillance
Liu, Y., Deisenroth, C., & Zhang, Y. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.03.002 · Cited by 127
The SUMO system controls nucleolar partitioning of a novel mammalian ribosome biogenesis complex
Finkbeiner, E., Haindl, M., & Müller, S. P. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.33 · Cited by 142
The ribosome, (slow) beating heart of cancer (stem) cell
Bastide, A., & David, A. (2018) · Oncogenesis · doi:10.1038/s41389-018-0044-8 · Cited by 140
Connections Between Metabolism and Epigenetics in Programming Cellular Differentiation
Chisolm, D. A., & Weinmann, A. S. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053127 · Cited by 122
Felsher, D. W. (2010) · Genes & Cancer · doi:10.1177/1947601910377798 · Cited by 124
Self-citationBoone, D. N., Qi, Y., Li, Z., & Hann, S. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008848108 · Cited by 122
Transient structure and dynamics in the disordered c-Myc transactivation domain affect Bin1 binding
Andresen, C., Helander, S., Lemak, A., Farès, C., Csizmok, V., Carlsson, J., Penn, L. Z., Forman-Kay, J. D., Arrowsmith, C. H., Lundström, P., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks263 · Cited by 117
Ribosome biogenesis and cancer
Derenzini, M., Montanaro, L., & Treré, D. (2017) · Acta Histochemica · doi:10.1016/j.acthis.2017.01.009 · Cited by 133
Global variability in gene expression and alternative splicing is modulated by mitochondrial content
Guantes, R., Rastrojo, A., Neves, R., Lima, A., Aguado, B., & Iborra, F. J. (2015) · Genome Research · doi:10.1101/gr.178426.114 · Cited by 119
Challagundla, K. B., Sun, X., Zhang, X., DeVine, T., Zhang, Q., Sears, R. C., & Dai, M. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05810-11 · Cited by 129
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis
Diolaiti, D., McFerrin, L., Carroll, P. A., & Eisenman, R. N. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.016 · Cited by 115
A liaison between mTOR signaling, ribosome biogenesis and cancer
Gentilella, A., Kozma, S. C., & Thomas, G. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.02.005 · Cited by 137
Wu, J., Subbaiah, K. C. V., Xie, L. H., Jiang, F., Khor, E.-S., Mickelsen, D. M., Myers, J. R., Tang, W. H. W., & Yao, P. (2020) · Circulation Research · doi:10.1161/circresaha.119.315999 · Cited by 120
Kawasaki, Y., Komiya, M., Matsumura, K., Negishi, L., Suda, S., Okuno, M., Yokota, N., Osada, T., Nagashima, T., Hiyoshi, M., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.015 · Cited by 116
Ribosomal proteins L5 and L11 co-operatively inactivate c-Myc via RNA-induced silencing complex
Liao, J.-M., Zhou, X. Y., Gatignol, A., & Lu, H. (2013) · Oncogene · doi:10.1038/onc.2013.430 · Cited by 121
MYC and Transcription Elongation
Rahl, P. B., & Young, R. A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a020990 · Cited by 110
CDK1 couples proliferation with protein synthesis
Haneke, K., Schott, J., Lindner, D., Hollensen, A. K., Damgaard, C. K., Mongis, C., Knop, M., Palm, W., Ruggieri, A., & Stoecklin, G. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201906147 · Cited by 132
Fei, L., Chen, H., Ma, L., Weigao, E., Wang, R., Fang, X., Zhou, Z., Sun, H., Wang, J., Jiang, M., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01118-8 · Cited by 122
Genome-wide mapping of Myc binding and gene regulation in serum-stimulated fibroblasts
Perna, D., Fagà, G., Verrecchia, A., Gorski, M. M., Barozzi, I., Narang, V, Khng, J., Lim, K. C., Sung, W.-K., Sanges, R., et al. (2012) · Oncogene · doi:10.1038/onc.2011.359 · Cited by 107
Molecular Pathways: Targeting MYC-induced Metabolic Reprogramming and Oncogenic Stress in Cancer
Li, B., & Simon, M. C. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3629 · Cited by 107
Regulation of translation by site-specific ribosomal RNA methylation
Jansson, M., Häfner, S. J., Altinel, K., Tehler, D., Krogh, N., Jakobsen, E., Andersen, J. V., Andersen, K. L., Schoof, E. M., Ménard, P., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00669-4 · Cited by 123
Stabilization of the c-Myc Protein by CAMKIIγ Promotes T Cell Lymphoma
Gu, Y., Zhang, J., Ma, X., Kim, B.-W., Wang, H., Li, J., Pan, Y., Xu, Y., Ding, L., Yang, L., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.001 · Cited by 107
LAS1L interacts with the mammalian Rix1 complex to regulate ribosome biogenesis
Castle, C. D., Cassimere, E. K., & Denicourt, C. (2012) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-06-0530 · Cited by 105
Therapeutic Targeting of Myc-Reprogrammed Cancer Cell Metabolism
Dang, C. V. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011296 · Cited by 105
Alterations in the ribosomal machinery in cancer and hematologic disorders
Shenoy, N. K., Kessel, R. M., Bhagat, T. D., Bhattacharyya, S., Yu, Y., McMahon, C. M., & Verma, A. K. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-32 · Cited by 118
Molecular definition of the pro‐tumorigenic phenotype of glioma‐activated microglia
Ellert‐Miklaszewska, A., Dąbrowski, M., Lipko, M. A., Sliwa, M., Maleszewska, M., & Kaminska, B. (2013) · Glia · doi:10.1002/glia.22510 · Cited by 109
Regulation of Cancer Metabolism by Oncogenes and Tumor Suppressors
Iurlaro, R., León‐Annicchiarico, C. L., & Muñoz‐Pinedo, C. (2014) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-416618-9.00003-0 · Cited by 130
Transcriptomic Analyses of Sexual Dimorphism of the Zebrafish Liver and the Effect of Sex Hormones
Zheng, W., Xu, H., Lam, S. H., Luo, H., Karuturi, R. K. M., & Gong, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053562 · Cited by 124
Signal Transduction in Ribosome Biogenesis: A Recipe to Avoid Disaster
Piazzi, M., Bavelloni, A., Gallo, A., Faenza, I., & Blalock, W. L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112718 · Cited by 119
Sun, X., DeVine, T., Challagundla, K. B., & Dai, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223651 · Cited by 112
MYC and therapy resistance in cancer: risks and opportunities
Donati, G., & Amati, B. B. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13319 · Cited by 114
Poortinga, G., Wall, M., Sanij, E., Siwicki, K., Ellul, J., Brown, D., Holloway, T. P., Hannan, R. D., & McArthur, G. A. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1205 · Cited by 101
Ribosomal proteins as unrevealed caretakers for cellular stress and genomic instability
Kim, T.-H., Leslie, P., & Zhang, Y. (2014) · Oncotarget · doi:10.18632/oncotarget.1784 · Cited by 100
When the good go bad: Mutant NPM1 in acute myeloid leukemia
Kunchala, P., Kuravi, S., Jensen, R. A., McGuirk, J. P., & Balusu, R. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.11.001 · Cited by 104
von Walden, F., Casagrande, V., Östlund Farrants, A.-K., & Nader, G. A. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00460.2011 · Cited by 100
Benefits of higher resistance-training volume are related to ribosome biogenesis
Hammarström, D., Øfsteng, S., Koll, L., Hanestadhaugen, M., Hollan, I., Apró, W., Whist, J. E., Blomstrand, E., Rønnestad, B. R., & Ellefsen, S. (2020) · The Journal of Physiology · doi:10.1113/jp278455 · Cited by 99
“Further supporting this view, mRNA expression of the transcription factor c-Myc, which is important for initiating rRNA transcription (van Riggelen et al. 2010), increased 1.58 [1.14–2.17]-fold more in response to multiple-set training than to single-set training (Fig.”
BackgroundInfluentialHe, L., Fan, Y., Zhang, Y., Tu, T.-T., Zhang, Q., Yuan, F., & Cheng, C. (2022) · Journal of Pineal Research · doi:10.1111/jpi.12803 · Cited by 105
Structure–function insights reveal the human ribosome as a cancer target for antibiotics
Myasnikov, A. G., Natchiar, S. K., Nebout, M., Hazemann, I., Imbert, V., Khatter, H., Peyron, J., & Klaholz, B. P. (2016) · Nature Communications · doi:10.1038/ncomms12856 · Cited by 109
Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma
Höllein, A., Fallahi, M., Schoeffmann, S., Steidle, S., Schaub, F. X., Rudelius, M., Laitinen, I., Nilsson, L. M., Goga, A., Peschel, C., et al. (2014) · Blood · doi:10.1182/blood-2014-06-584524 · Cited by 102
Teng, T., Mercer, C. A., Hexley, P., Thomas, G., & Fumagalli, S. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01174-13 · Cited by 98
The long noncoding RNA glycoLINC assembles a lower glycolytic metabolon to promote glycolysis
Zhu, Y., Jin, L., Shi, R., Li, J., Wang, Y., Zhang, L., chao-zhao, L., Narayana, V. K., Souza, D. P. D., Thorne, R. F., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.11.017 · Cited by 106
Guarding the ‘translation apparatus’: defective ribosome biogenesis and the p53 signaling pathway
Chakraborty, A., Uechi, T., & Kenmochi, N. (2011) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.73 · Cited by 111
Kim, D. W., Wu, N., Kim, Y., Cheng, P. F., Basom, R., Kim, D., Dunn, C. T., Lee, A. Y., Kim, K., Lee, C. S., et al. (2016) · Genes & Development · doi:10.1101/gad.279307.116 · Cited by 103
Grewal, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.12.005 · Cited by 107
MYC Regulation of Cell Growth through Control of Transcription by RNA Polymerases I and III
Campbell, K. J., & White, R. J. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a018408 · Cited by 94
Downregulation of ribosome biogenesis during early forebrain development
Chau, K. F., Shannon, M. L., Fame, R. M., Fonseca, E., Mullan, H., Johnson, M. B., Sendamarai, A. K., Springel, M. W., Laurent, B., & Lehtinen, M. K. (2018) · eLife · doi:10.7554/elife.36998 · Cited by 93
Popay, T. M., Wang, J., Adams, C. M., Howard, G. C., Codreanu, S. G., Sherrod, S. D., MCLEAN, J. A. J., Thomas, L. R., Lorey, S. L., Machida, Y., et al. (2021) · eLife · doi:10.7554/elife.60191 · Cited by 99
Montanaro, L., Treré, D., & Derenzini, M. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2011.10.006 · Cited by 112
Translation factors and ribosomal proteins control tumor onset and progression: how?
Loreni, F., Mancino, M., & Biffo, S. (2013) · Oncogene · doi:10.1038/onc.2013.153 · Cited by 103
The complex role of SIRT6 in carcinogenesis
Lerrer, B., Gertler, A. A., & Cohen, H. Y. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv167 · Cited by 92
Transcriptional Maintenance of Pancreatic Acinar Identity, Differentiation, and Homeostasis by PTF1A
Hoang, C. Q., Hale, M. A., Azevedo-Pouly, A. C., Elsässer, H. P., Deering, T. G., Willet, S. G., Pan, F. C., Magnuson, M. A., Wright, C. V. E., Swift, G. H., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-16 · Cited by 91
Ribosomopathies: Mechanisms of Disease
Nakhoul, H. N., Ke, J., Zhou, X. Y., Liao, W., Zeng, S. X., & Lu, H. (2014) · Plasmatology · doi:10.4137/cmbd.s16952 · Cited by 102
Targeting Synthetic Lethal Interactions between Myc and the eIF4F Complex Impedes Tumorigenesis
Lin, C.-J., Nasr, Z., Premsrirut, P. K., Porco, J. A., Hippo, Y., Lowe, S. W., & Pelletier, J. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.02.010 · Cited by 90
Size control: the developmental physiology of body and organ size regulation
Gokhale, R. H., & Shingleton, A. W. (2015) · Wiley Interdisciplinary Reviews Developmental Biology · doi:10.1002/wdev.181 · Cited by 106
Myc as a Regulator of Ribosome Biogenesis and Cell Competition: A Link to Cancer
Destefanis, F., Manara, V., & Bellosta, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114037 · Cited by 100
Translational control in germline stem cell development
Slaidina, M., & Lehmann, R. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201407102 · Cited by 95
Sakamoto, K., Katayama, R., Asaka, R., Sakata, S., Baba, S., Nakasone, H., Koike, S., Tsuyama, N., Dobashi, A., Sasaki, M., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0154-5 · Cited by 87
Song, Y., & Lu, B. (2011) · Genes & Development · doi:10.1101/gad.171959.111 · Cited by 86
Metabolic regulation of somatic stem cells in vivo
Meacham, C. E., DeVilbiss, A. W., & Morrison, S. J. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00462-1 · Cited by 85
Matkar, S., Sharma, P., Gao, S., Gurung, B., Katona, B. W., Liao, J., Muhammad, A. B., Kong, X.-C., Wang, L., Jin, G., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.005 · Cited by 85
Translational development of difluoromethylornithine (DFMO) for the treatment of neuroblastoma.
Bassiri, H., Benavides, A. D., Haber, M., Gilmour, S. K., Norris, M. D., & Hogarty, M. D. (2015) · PubMed · doi:10.3978/j.issn.2224-4336.2015.04.06 · Cited by 96
The homeostatic regulation of ribosome biogenesis
Ni, C., & Buszczak, M. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.03.043 · Cited by 101
Luo, H., Chen, Z., Wang, S., Zhang, R., Qiu, W., Zhao, L., Peng, C., Xu, R., Chen, W., Wang, H., et al. (2015) · Brain · doi:10.1093/brain/awv287 · Cited by 85
Functional Dynamics within the Human Ribosome Regulate the Rate of Active Protein Synthesis
Ferguson, A., Wang, L., Altman, R. B., Terry, D. S., Juette, M. F., Burnett, B. J., Alejo, J. L. P., Dass, R. A., Parks, M., Vincent, C. T., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.013 · Cited by 101
Polyamine Antagonist Therapies Inhibit Neuroblastoma Initiation and Progression
Evageliou, N. F., Haber, M., Vu, A. T., Laetsch, T. W., Murray, J. E., Gamble, L. D., Cheng, N. C., Liu, K., Reese, M., Corrigan, K. A., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2539 · Cited by 93
CDK12 phosphorylates 4E-BP1 to enable mTORC1-dependent translation and mitotic genome stability
Choi, S. H., Martinez, T. F., Kim, S., Donaldson, C. J., Shokhirev, M. N., Saghatelian, A., & Jones, K. A. (2019) · Genes & Development · doi:10.1101/gad.322339.118 · Cited by 95
Ribosome biogenesis is necessary for skeletal muscle hypertrophy
Wen, Y., Alimov, A. P., & McCarthy, J. J. (2016) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000082 · Cited by 82
“Copyright © 2016 by the American College of Sports Medicin its regulation of all three RNA polymerases and, by extension, their respective gene products such as Pol I regulon components, ribosomal proteins, and 5S rRNA (32).”
BackgroundPunyawatthananukool, S., Matsuura, R., Wongchang, T., Katsurada, N., Tsuruyama, T., Tajima, M., Enomoto, Y., Kitamura, T., Kawashima, M., Toi, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53706-3 · Cited by 103
SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency
Herranz, D., Maraver, A., Cañamero, M., Goméz-López, G., Inglada‐Pérez, L., Robledo, M., Castelblanco, E., Matías‐Guiu, X., & Serrano, M. (2012) · Oncogene · doi:10.1038/onc.2012.407 · Cited by 91
Li, L., Chen, H., Hsieh, Y., Wang, Y., Chu, H.-J., Chen, Y.-H., Chen, H., Chien, P., Ma, H.-T., Tsai, H.-C., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3504 · Cited by 96
Targeting the eIF4A RNA helicase as an anti-neoplastic approach
Chu, J., & Pelletier, J. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.09.006 · Cited by 91
Tan, T. C. J., Knight, J., Sbarrato, T., Dudek, K., Willis, A. E., & Zamoyska, R. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1700939114 · Cited by 79
Emerging Role of Eukaryote Ribosomes in Translational Control
Venezia, N. D., Vincent, A., Marcel, V., Catez, F., & Diaz, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051226 · Cited by 93
Wnts and the hallmarks of cancer
Zhong, Z., Yu, J., Virshup, D. M., & Madan, B. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09887-6 · Cited by 85
Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward
Zisi, A., Bártek, J., & Lindström, M. S. (2022) · Cancers · doi:10.3390/cancers14092126 · Cited by 92
Stimulation of mTORC1 with L-leucine Rescues Defects Associated with Roberts Syndrome
Xu, B., Lee, K. K., Zhang, L., & Gerton, J. L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003857 · Cited by 81
Limonene inhibits Candida albicans growth by inducing apoptosis
Thakre, A. D., Zore, G. B., Kodgire, S., Kazi, R. S., Mulange, S. V., Patil, R., Shelar, A. V., Santhakumari, B., Kulkarni, M. J., Kharat, K. R., et al. (2017) · Medical Mycology · doi:10.1093/mmy/myx074 · Cited by 106
Human MYC G-quadruplex: From discovery to a cancer therapeutic target
Wang, W., Hu, S., Gu, Y., Yan, Y., Stovall, D. B., Li, D., & Sui, G. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188410 · Cited by 88
Smit, W. L., Spaan, C. N., Johannes de Boer, R., Ramesh, P., Martins Garcia, T., Meijer, B. J., Vermeulen, J. L. M., Lezzerini, M., MacInnes, A. W., Koster, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1912772117 · Cited by 77
Las1L Is a Nucleolar Protein Required for Cell Proliferation and Ribosome Biogenesis
Castle, C. D., Cassimere, E. K., Lee, J., & Denicourt, C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00358-10 · Cited by 83
Targeting RNA polymerase I to treat MYC-driven cancer
Poortinga, G., Quinn, L. M., & Hannan, R. D. (2014) · Oncogene · doi:10.1038/onc.2014.13 · Cited by 83
Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer
Huang, F., Huffman, K. E., Wang, Z., Wang, X., Li, K., Cai, F., Yang, C., Cai, L., Shih, T. S., Zacharias, L. G., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci139929 · Cited by 80
The impact of MYC expression in lymphoma biology: Beyond Burkitt lymphoma
Smith, S. M., Anastasi, J., Cohen, K. S., & Godley, L. A. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.08.002 · Cited by 78
Wasylishen, A. R., & Penn, L. Z. (2010) · Genes & Cancer · doi:10.1177/1947601910378024 · Cited by 90
Lee, H. C., Wang, H., Baladandayuthapani, V., Lin, H. Y., He, J., Jones, R. J., Kuiatse, I., Gu, D., Wang, Z., Ma, W., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.14525 · Cited by 86
Chen, K., Hsu, W.-H., Ho, J.-Y., Lin, C.-W., Chu, C.-Y., Kandaswami, C. C., Lee, M., & Cheng, C. (2018) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2018.01.012 · Cited by 71
Andrews, W. J., Panova, T. B., Normand, C., Gadal, O., Tikhonova, I. G., & Panov, K. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.411611 · Cited by 74
Li, Z., Zheng, W., Wang, Z., Zeng, Z., Zhan, H., Li, C., Zhou, L. Q., Yan, C., Spitsbergen, J. M., & Gong, Z. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010462 · Cited by 71
Ribosome Biogenesis Alterations in Colorectal Cancer
Nait-Slimane, S., Marcel, V., Fenouil, T., Catez, F., Saurin, J., Bouvet, P., Diaz, J., & Mertani, H. C. (2020) · Cells · doi:10.3390/cells9112361 · Cited by 84
The impact of ribosome biogenesis in cancer: from proliferation to metastasis
Hwang, S.-P., & Denicourt, C. (2024) · NAR Cancer · doi:10.1093/narcan/zcae017 · Cited by 90
The Interplay between Myc and CTP Synthase in Drosophila
Aughey, G., Grice, S. J., & Liu, J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005867 · Cited by 70
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 77
m6A RNA methylation impacts fate choices during skin morphogenesis
Xi, L., Carroll, T., Matos, I., Luo, J., Polak, L., Pasolli, H. A., Jaffrey, S. R., & Fuchs, E. V. (2020) · eLife · doi:10.7554/elife.56980 · Cited by 83
Wang, S., Cheng, Y., Du, W., Lu, L., Zhou, L., Wang, H., Kang, W., Li, X., Tao, Q., Sung, J. J. �., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301776 · Cited by 72
Temporal dynamics of Wnt-dependent transcriptome reveal an oncogenic Wnt/MYC/ribosome axis
Madan, B., Harmston, N., Nallan, G., Montoya, A., Faull, P. A., Petretto, E. G., & Virshup, D. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122383 · Cited by 70
Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
Hald, Ø. H., Olsen, L., Gallo-Oller, G., Elfman, L. H. M., Løkke, C., Kogner, P., Sveinbjørnsson, B., Flægstad, T., Johnsen, J. I., & Einvik, C. (2018) · Oncogene · doi:10.1038/s41388-018-0611-7 · Cited by 69
Metadata
- Authors
- van Riggelen, J., Yetil, A., & Felsher, D. W.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Felsher, Dean W.
- ORCID
- Felsher, Dean W.
- Venue
- Nature Reviews Cancer
- Published
- 2010-04
- Volume
- 10
- Issue
- 4
- Pages
- 301-309
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2021764678
- Cited by
- 956
- References
- 126
- Citations by year
- 2026: 59 · 2025: 65 · 2024: 94 · 2023: 72 · 2022: 61 · 2021: 68 · 2020: 75 · 2019: 63 · 2018: 50 · 2017: 57 · 2016: 48 · 2015: 57 · 2014: 53 · 2013: 43 · 2012: 39
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Burroughs Wellcome Fund
- Leukemia and Lymphoma Society
- Canada Research Chairs
- National Institutes of Health
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- c-Myc, ribosome biogenesis, protein synthesis, rRNA processing, translation initiation, transcriptional regulation, carcinogenesis, cell proliferation
- MeSH terms
- Gene Expression Regulation, Homeostasis, Humans, Models, Genetic, Neoplasms, Ribosomal Proteins, Ribosomes, RNA, Messenger, Protein Biosynthesis, Genes, myc, Proto-Oncogene Proteins c-myc
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.